Event today: Discover residual DNA quantitation using digital PCR

A strip of 8 PCR tubes on the thermal cycler

Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’.

This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior Manager, Product Management, as well as Viki Mahen, Scientist III, Molecular Biology.

Leveraging digital PCR-based assays for the quantitation of residual host cell DNA or viral titres within a biotherapeutic manufacturing workflow offers significant value in ensuring product quality and safety. Digital PCR, or dPCR, is a highly sensitive and precise technique that enables the absolute quantification of nucleic acid targets.

In the context of biotherapeutic manufacturing, dPCR provides a robust and accurate method for measuring residual host cell DNA or viral titres, which are critical parameters to assess the purity and potency of biopharmaceutical products. By employing dPCR-based assays, manufacturers can effectively monitor and control the levels of impurities, ensuring compliance with regulatory guidelines and minimising the risk of adverse effects in patients.

Additionally, dPCR’s ability to detect low copy numbers and its resistance to PCR inhibitors make it a great analytical tool for biopharma. Overall, leveraging digital PCR-based assays enhances the efficiency, reliability, and quality of biotherapeutic manufacturing workflows, contributing to the development of safe and effective biopharmaceutical products.

What you will learn:

  • The benefits of using the latest innovative solutions to quantitate host cell DNA or viral titres within a biotherapeutic manufacturing workflow
  • Regulatory compliance with regards to process impurity testing
  • How an integrated workflow solution supports process development and a cGMP environment

Secure your free place today.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free